France Cannabidiol Market Size, Share, and COVID-19 Impact Analysis, By Source Type (Hemp and Marijuana), By Sales Type (B2B and B2C), and France Cannabidiol Market Insights, Industry Trend, Forecasts to 2035
Industry: HealthcareFrance Cannabidiol Market Insights Forecasts to 2035
- The France Cannabidiol Market Size was Estimated at USD 36.7 Million in 2024
- The Market Size is Expected to Grow at a CAGR of around 22.25% from 2025 to 2035
- The France Cannabidiol Market Size is Expected to Reach USD 334.5 Million by 2035
Get more details on this report -
According to a research report published by Spherical Insights and Consulting, The France Cannabidiol Market Size is anticipated to reach USD 334.5 Million by 2035, growing at a CAGR of 22.25% from 2025 to 2035. The France cannabidiol market is growing due to the growing interest in cannabidiol's possible health benefits has prompted more money to be spent on research and development in order to better understand its effects and create new products.
Market Overview
The France Cannabidiol (CBD) Market refers to the sale, distribution, or exchange of Cannabidiol (CBD) (i.e., a chemical compound found in the cannabis plant) products in France. This market will include products, including CDB oils, edibles, topicals, and capsules, that are sold in all different types of outlets (i.e., health food stores, pharmacies, online, specialty stores) in France. The France Cannabidiol market exists partly due to the therapeutic promise of CBD, including pain relief and reducing anxiety, and a shift in consumer behavior towards natural and alternative methods to enhance well-being. As a part of the expansion of legal hemp-based products, the size of the CBD market will continue to grow. Many brands are creating products of all types, including edibles, toppings, beverages, etc, that are based on consumers' demand for cannabidiol products and to capitalize on the growing market and the explosive growth of e-commerce. E-commerce allows brands to increase marketability regarding how customers can access and purchase their product, which is contributing to the growth of the CBD industry acquisition projections.
Report Coverage
This research report categorizes the market for the France cannabidiol market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the France cannabidiol market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the France cannabidiol market.
France Cannabidiol Market Report Coverage
Report Coverage | Details |
---|---|
Base Year: | 2024 |
Market Size in 2024: | USD 36.7 Million |
Forecast Period: | 2025-2035 |
Forecast Period CAGR 2025-2035 : | CAGR Of 22.25% |
2035 Value Projection: | USD 334.5 Million |
Historical Data for: | 2020-2023 |
No. of Pages: | 255 |
Tables, Charts & Figures: | 109 |
Segments covered: | By Source Type and By Sales Type |
Companies covered:: | ENDOCA, NuLeaf Naturals, LLC, Medical Marijuana, Inc., The Cronos Group, Elixinol, PharmaHemp, and Others |
Pitfalls & Challenges: | Covid-19 Empact,Challenges,Growth, Analysis. |
Get more details on this report -
Driving Factors
Market forces in the France cannabidiol (CBD) market include increasing demand for CBD products from consumers and expanding awareness of their potential health benefits, and the legalisation of CBD products in France. The increasing application of products that contain CBD, the trend toward natural alternatives, and the regulatory environment will also help market growth. Based on our analysis of cannabidiol (CBD) industry statistics, we have established the level of market growth stage as high, and the pace of market growth is accelerating. The Cannabidiol market is characterized by a very high level of innovation based on increased R&D of cannabis properties and its medical benefits, increased demand for its health benefits without intoxication, and increased preference for cannabis extracts (oils, tinctures, etc).
Restraining Factors
The France CBD market faces challenges with regard to regulation, consumer understanding, and product quality. Regulatory uncertainty and differing interpretations of existing laws nationally can slow market development. Consumer perceptions of CBD products can be impacted by the association with cannabis, and can cause further regulatory and market development hardships, especially for those aged 50 and over. Product quality and safety concerns, including batch potency and the existence of contaminants or mixed products, also remain an impediment to market success.
Market Segmentation
The France cannabidiol market share is classified into source type and sales type.
- The hemp segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period.
The France cannabidiol market is segmented by source type into hemp and marijuana. Among these, the hemp segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to growing consumer awareness of health benefits and increased demand from the pharmaceutical industry, this segment is anticipated to grow at the fastest rate. The demand for cannabidiol in the pharmaceutical industry is also anticipated to increase as a result of the legalization of medical cannabis and rising consumer disposable income.
- The B2B segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.
The France cannabidiol market is segmented by sales type into B2B and B2C. Among these, the B2B segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to the increasing number of wholesalers selling CBD oil and the rising demand for the raw material. Additionally, the growing consumer base brought about by the legalization of CBD products in several nations has increased supply opportunities.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the France cannabidiol market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Companies
- ENDOCA
- NuLeaf Naturals, LLC
- Medical Marijuana, Inc.
- The Cronos Group
- Elixinol
- PharmaHemp
- Others
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at the global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the France cannabidiol market based on the below-mentioned segments:
France Cannabidiol Market, By Source Type
- Hemp
- Marijuana
France Cannabidiol Market, By Sales Type
- B2B
- B2C
Need help to buy this report?